{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:01:06Z","timestamp":1771567266103,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/gt.2017.96","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T15:41:11Z","timestamp":1509982871000},"page":"757-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adipose tissue: a new target for electroporation-enhanced DNA vaccines"],"prefix":"10.1038","volume":"24","author":[{"given":"P D","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"Brambila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W B","family":"Kiosses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B S","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T R F","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K E","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"BFgt201796_CR1","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/S0264-410X(98)00180-7","volume":"16","author":"KE Ugen","year":"1998","unstructured":"Ugen KE, Nyland SB, Boyer JD, Vidal C, Lera L, Rasheid S et al. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 1998; 16: 1818\u20131821.","journal-title":"Vaccine"},{"key":"BFgt201796_CR2","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0264-410X(99)00407-7","volume":"18","author":"TP Le","year":"2000","unstructured":"Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M, Epstein JE et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 2000; 18: 1893\u20131901.","journal-title":"Vaccine"},{"key":"BFgt201796_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/515613","volume":"178","author":"RR MacGregor","year":"1998","unstructured":"MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 1998; 178: 92\u2013100.","journal-title":"J Infect Dis"},{"key":"BFgt201796_CR4","first-page":"893","volume":"321","author":"LM Mir","year":"1998","unstructured":"Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D . Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. Comptes Rendus l\u2019Acad\u00e9mie des Sci Ser III Sci la Vie 1998; 321: 893\u2013899.","journal-title":"Comptes Rendus l\u2019Acad\u00e9mie des Sci Ser III Sci la Vie"},{"key":"BFgt201796_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.gt.3300847","volume":"6","author":"I Mathiesen","year":"1999","unstructured":"Mathiesen I . Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Therapy 1999; 6: 508\u2013514.","journal-title":"Gene Therapy"},{"key":"BFgt201796_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/hum.2009.067","volume":"20","author":"L Low","year":"2009","unstructured":"Low L, Mander A, McCann K, Dearnaley D, Tjelle T, Mathiesen I et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009; 20: 1269\u20131278.","journal-title":"Hum Gene Ther"},{"key":"BFgt201796_CR7","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1016\/j.vaccine.2007.03.009","volume":"25","author":"C Tsang","year":"2007","unstructured":"Tsang C, Babiuk S, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel P . A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 2007; 25: 5485\u20135494.","journal-title":"Vaccine"},{"key":"BFgt201796_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","volume":"28","author":"BD Livingston","year":"2010","unstructured":"Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D . Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 2010; 28: 1056\u20131061.","journal-title":"Vaccine"},{"key":"BFgt201796_CR9","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/mt.2013.119","volume":"21","author":"O Weiland","year":"2013","unstructured":"Weiland O, Ahl\u00e9n G, Diepolder H, Jung M-C, Levander S, Fons M et al. Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C. Mol Ther 2013; 21: 1796\u20131805.","journal-title":"Mol Ther"},{"key":"BFgt201796_CR10","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1016\/j.vaccine.2010.12.055","volume":"29","author":"J Yin","year":"2011","unstructured":"Yin J, Dai A, Lecureux J, Arango T, Kutzler MA, Yan J et al. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Vaccine 2011; 29: 6763\u20136770.","journal-title":"Vaccine"},{"key":"BFgt201796_CR11","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1016\/j.vaccine.2009.07.005","volume":"27","author":"SR Best","year":"2009","unstructured":"Best SR, Peng S, Juang C-M, Hung C-F, Hannaman D, Saunders JR et al. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009; 27: 5450\u20135459.","journal-title":"Vaccine"},{"key":"BFgt201796_CR12","doi-asserted-by":"publisher","first-page":"155ra138","DOI":"10.1126\/scitranslmed.3004414","volume":"4","author":"ML Bagarazzi","year":"2012","unstructured":"Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC et al. Immunotherapy against HPV16\/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 2012; 4: 155ra138.","journal-title":"Sci Transl Med"},{"key":"BFgt201796_CR13","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","volume":"386","author":"CL Trimble","year":"2015","unstructured":"Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet 2015; 386: 2078\u20132088.","journal-title":"Lancet"},{"key":"BFgt201796_CR14","doi-asserted-by":"publisher","first-page":"14054","DOI":"10.1038\/mtm.2014.54","volume":"1","author":"TR Smith","year":"2014","unstructured":"Smith TR, Schultheis K, Kiosses WB, Amante DH, Mendoza JM, Stone JC et al. DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Mol Ther Methods Clin Dev 2014; 1: 14054.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"BFgt201796_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/gt.2010.137","volume":"18","author":"KE Broderick","year":"2011","unstructured":"Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Therapy 2011; 18: 258\u2013265.","journal-title":"Gene Therapy"},{"key":"BFgt201796_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.vaccine.2007.10.041","volume":"26","author":"LA Hirao","year":"2008","unstructured":"Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB . Intradermal\/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 2008; 26: 440\u2013448.","journal-title":"Vaccine"},{"key":"BFgt201796_CR17","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","volume":"25","author":"JW Hooper","year":"2007","unstructured":"Hooper JW, Golden JW, Ferro AM, King AD . Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007; 25: 1814\u20131823.","journal-title":"Vaccine"},{"key":"BFgt201796_CR18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2147\/PPA.S87271","volume":"9","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Jin J, Zhu L, Chen M, Xu H, Wang H et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence 2015; 9: 923.","journal-title":"Patient Prefer Adherence"},{"key":"BFgt201796_CR19","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548\u20132556.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201796_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/PNS200194","volume":"60","author":"P Trayhurn","year":"2001","unstructured":"Trayhurn P, Beattie JH . Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329\u2013339.","journal-title":"Proc Nutr Soc"},{"key":"BFgt201796_CR21","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.2337\/db12-1404","volume":"62","author":"DL Morris","year":"2013","unstructured":"Morris DL, Cho KW, Delproposto JL, Oatmen KE, Geletka LM, Martinez-Santibanez G et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013; 62: 2762\u20132772.","journal-title":"Diabetes"},{"key":"BFgt201796_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ijo.2015.145","volume":"40","author":"L Xiao","year":"2016","unstructured":"Xiao L, Yang X, Lin Y, Li S, Jiang J, Qian S et al. Large adipocytes function as antigen-presenting cells to activate CD4+ T cells via upregulating MHCII in obesity. Int J Obes 2016; 40: 112\u2013120.","journal-title":"Int J Obes"},{"key":"BFgt201796_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/hgtb.2015.020","volume":"26","author":"DH Amante","year":"2015","unstructured":"Amante DH, Smith TRF, Mendoza JM, Schultheis K, McCoy JR, Khan AS et al. Skin transfection patterns and expression kinetics of electroporation-enhanced plasmid delivery using the CELLECTRA-3P, a portable next-generation dermal electroporation device. Hum Gene Ther Methods 2015; 26: 134\u2013146.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt201796_CR24","first-page":"60","volume":"9","author":"R Kjeken","year":"2004","unstructured":"Kjeken R, Tjelle TE, Kvale D, Mathiesen I . Clinical evaluation of pain and muscle damage induced by electroporation of skeletal muscle in humans. Mol Ther 2004; 9: 60.","journal-title":"Mol Ther"},{"key":"BFgt201796_CR25","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.4161\/hv.24702","volume":"9","author":"MC Diehl","year":"2013","unstructured":"Diehl MC, Lee JC, Daniels SE, Tebas P, Khan AS, Giffear M et al. Tolerability of intramuscular and intradermal delivery by CELLECTRA(\u00ae) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother 2013; 9: 2246\u20132252.","journal-title":"Hum Vaccin Immunother"},{"key":"BFgt201796_CR26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/mt.2009.27","volume":"17","author":"M Wallace","year":"2009","unstructured":"Wallace M, Evans B, Woods S, Mogg R, Zhang L, Finnefrock AC et al. Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults. Mol Ther 2009; 17: 922\u2013928.","journal-title":"Mol Ther"},{"key":"BFgt201796_CR27","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1016\/j.vaccine.2016.09.041","volume":"34","author":"P Spearman","year":"2016","unstructured":"Spearman P, Mulligan M, Anderson EJ, Shane AL, Stephens K, Gibson T et al. A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation. Vaccine 2016; 34: 5571\u20135578.","journal-title":"Vaccine"},{"key":"BFgt201796_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/mt.2011.235","volume":"20","author":"SS El-Kamary","year":"2012","unstructured":"El-Kamary SS, Billington M, Deitz S, Colby E, Rhinehart H, Wu Y et al. Safety and tolerability of the Easy VaxTM clinical epidermal electroporation system in healthy adults. Mol Ther 2012; 20: 214\u2013220.","journal-title":"Mol Ther"},{"key":"BFgt201796_CR29","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1038\/oby.2008.351","volume":"16","author":"Y Wang","year":"2008","unstructured":"Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK . Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008; 16: 2323\u20132330.","journal-title":"Obesity (Silver Spring)"},{"key":"BFgt201796_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.ijo.0802326","volume":"27","author":"KN Frayn","year":"2003","unstructured":"Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW . Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003; 27: 875\u2013888.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFgt201796_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nature06902","volume":"453","author":"KL Spalding","year":"2008","unstructured":"Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783\u2013787.","journal-title":"Nature"},{"key":"BFgt201796_CR32","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548\u20132556.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201796_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/sj.ijo.0800770","volume":"22","author":"V Mohamed-Ali","year":"1998","unstructured":"Mohamed-Ali V, Pinkney JH, Coppack SW . Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145\u20131158.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFgt201796_CR34","doi-asserted-by":"publisher","first-page":"E574","DOI":"10.1152\/ajpendo.00567.2003","volume":"287","author":"JG Granneman","year":"2004","unstructured":"Granneman JG, Li P, Lu Y, Tilak J . Seeing the trees in the forest: selective electroporation of adipocytes within adipose tissue. Am J Physiol Endocrinol Metab 2004; 287: E574\u2013E582.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFgt201796_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0304-4165(99)00094-X","volume":"1428","author":"J Gehl","year":"1999","unstructured":"Gehl J, S\u00f8rensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428: 233\u2013240.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201796_CR36","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/hum.2008.060","volume":"19","author":"FM Andr\u00e9","year":"2008","unstructured":"Andr\u00e9 FM, Gehl J, Sersa G, Pr\u00e9at V, Hojman P, Eriksen J et al. Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008; 19: 1261\u20131271.","journal-title":"Hum Gene Ther"},{"key":"BFgt201796_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0304-4165(00)00101-X","volume":"1523","author":"D Miklavcic","year":"2000","unstructured":"Miklavcic D, Semrov D, Mekid H, Mir LM . A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201796_CR38","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1109\/TBME.2005.845212","volume":"52","author":"D Sel","year":"2005","unstructured":"Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D . Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 2005; 52: 816\u2013827.","journal-title":"IEEE Trans Biomed Eng"},{"key":"BFgt201796_CR39","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1021\/ac062049e","volume":"79","author":"A Agarwal","year":"2007","unstructured":"Agarwal A, Zudans I, Weber EA, Olofsson J, Orwar O, Weber SG . Effect of cell size and shape on single-cell electroporation. Anal Chem 2007; 79: 3589\u20133596.","journal-title":"Anal Chem"},{"key":"BFgt201796_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4161\/21645515.2014.978223","volume":"11","author":"JR McCoy","year":"2015","unstructured":"McCoy JR, Mendoza JM, Spik KW, Badger C, Gomez AF, Schmaljohn CS et al. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. Hum Vaccin Immunother 2015; 11: 746\u2013754.","journal-title":"Hum Vaccin Immunother"},{"key":"BFgt201796_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nbt0998-867","volume":"16","author":"H Aihara","year":"1998","unstructured":"Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867\u2013870.","journal-title":"Nat Biotechnol"},{"key":"BFgt201796_CR42","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/JVI.02564-07","volume":"82","author":"J Liu","year":"2008","unstructured":"Liu J, Kjeken R, Mathiesen I, Barouch DH . Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol 2008; 82: 5643\u20135649.","journal-title":"J Virol"},{"key":"BFgt201796_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bioelechem.2003.07.001","volume":"61","author":"RV Davalos","year":"2003","unstructured":"Davalos RV, Rubinsky B, Mir LM . Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 2003; 61: 99\u2013107.","journal-title":"Bioelectrochemistry"},{"key":"BFgt201796_CR44","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1517\/14712598.8.11.1645","volume":"8","author":"P Chiarella","year":"2008","unstructured":"Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM et al. Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 2008; 8: 1645\u20131657.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt201796_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbiotec.2004.01.015","volume":"110","author":"S Babiuk","year":"2004","unstructured":"Babiuk S, Baca-Estrada ME, Foldvari M, Middleton DM, Rabussay D, Widera G et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110: 1\u201310.","journal-title":"J Biotechnol"},{"key":"BFgt201796_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0006-3495(98)74008-1","volume":"74","author":"YA Chizmadzhev","year":"1998","unstructured":"Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko S V, Weaver JC, Potts RO . Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 1998; 74: 843\u2013856.","journal-title":"Biophys J"},{"key":"BFgt201796_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-1-4615-4867-6_58","volume-title":"Electricity and Magnetism in Biology and Medicine","author":"U Pliquett","year":"1999","unstructured":"Pliquett U, Weaver JC Passive electrical properties of human stratum corneum during application of electric fields. In: Bersani F (Ed.). Electricity and Magnetism in Biology and Medicine. Springer US: Boston, MA, 1999, pp 259\u2013262."},{"key":"BFgt201796_CR48","volume-title":"Wiley Encyclopedia of Biomedical Engineering","author":"D Miklav\u010di\u010d","year":"2006","unstructured":"Miklav\u010di\u010d D, Pav\u0161elj N, Hart FX, Miklav\u010di\u010d D, Pav\u0161elj N, Hart FX Electric properties of tissues. In: Akay M (ed.). Wiley Encyclopedia of Biomedical Engineering. John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2006."},{"key":"BFgt201796_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D . A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998; 221: 35\u201341.","journal-title":"J Immunol Methods"},{"key":"BFgt201796_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vaccine.2016.11.052","volume":"35","author":"K Schultheis","year":"2017","unstructured":"Schultheis K, Schaefer H, Yung BS, Oh J, Muthumani K, Humeau L et al. Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine 2017; 35: 61\u201370.","journal-title":"Vaccine"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gt201796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201796","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/gt.2017.96","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/gt201796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:34:33Z","timestamp":1684431273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFgt201796"],"URL":"https:\/\/doi.org\/10.1038\/gt.2017.96","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"assertion":[{"value":"30 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PDF, CJB, JRM, JMM, JO, BSY, KS, TRFS and KEB are employees of Inovio Pharmaceuticals, and own shares or stock options in the company. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}